Vanberra Signal

Akers Bio

Curated by Signal

Rapid point-of-care diagnostics and testing products

Overview

Akers Bio develops rapid point-of-care diagnostics and testing products. It has three main product lines: clinical diagnostics which includes tests for heparin-induced thrombocytopenia and malaria; disposable breath alcohol tests; and consumer monitoring diagnostics which includes the BreathScan Lync Reader and associated tests for monitoring nutritional ketosis, oxidative stress and free radicals, and cholesterol. These tests use a combination of proprietary technologies like Particle Immuno-Filtration Assay (PIFA®) Technology, Micro Particle Catalyzed (MPC®) Biosensor, seraSTAT® Rapid Blood Cell Separation, Rapid Enzymatic Assay (REA™), Synthetic Macrocycle Complex (SMC™) and minDNA™, all of which are also available for out-licensing.

Key facts

Founded
1989

Contact

More on Vanberra Signal

Members only

Competitors & similar companies

More Health Technology companies
  • Provider of cloud-based practice management software for clinics

    Health TechnologyFort Lauderdale, United States
  • Mobile-based social application for multiple health conditions

    Health TechnologySan Francisco, United States
  • Randomization and Trial Supply Management (RTSM) solutions for clinical trials

    Health TechnologyDover, United States

About Akers Bio

What does Akers Bio do?

Akers Bio develops rapid point-of-care diagnostics and testing products.

Where is Akers Bio headquartered?

Akers Bio is headquartered in West Deptford, United States.

When was Akers Bio founded?

Akers Bio was founded in 1989.

Which sector is Akers Bio in?

Akers Bio operates in Health Technology.

Who are Akers Bio's competitors?

Companies similar to Akers Bio include COMPASS, MyHealthTeam, and 4G Clinical.